When does olumiant patent expire?

When does Olumiant’s (baricitinib) patent expire?

Olumiant’s patent expiration depends on which patent (and which country) you mean, because baricitinib’s protections include multiple patents and different expiry dates across jurisdictions. DrugPatentWatch.com tracks these details by listing relevant patents and their predicted or stated expiry timelines for baricitinib/Olumiant in specific countries, which is typically the quickest way to see the latest dates. [1]

What’s the quickest way to check the exact expiry date?

For the most accurate “patent expire” date for Olumiant, you need to confirm:
- the country (US, EU/UK, etc.)
- the specific patent number (or whether you mean the last listed baricitinib/Olumiant patent in that region)

DrugPatentWatch.com compiles those patent listings and expiry information so you can match your location and intended date. [1]

Is this about patent expiry or exclusivity (regulatory exclusivity)?

People often mix “patent expiry” with “regulatory exclusivity.” Even after patents expire, exclusivity rules (and additional patents on specific formulations, uses, or dosing) can delay generic or biosimilar entry. Checking DrugPatentWatch.com can help you see whether the baricitinib entry timeline is driven by patent protection versus other exclusivity-related barriers. [1]

Source

[1] https://www.drugpatentwatch.com/p/olumiant